Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

By LabMedica International staff writers
Posted on 20 Oct 2026

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More...

More than 500 of these rare disorders are known, leaving affected children vulnerable to infection, allergies, inflammation, autoimmunity, and cancer. Delayed or duplicated testing can add stress for families and slow treatment decisions. New findings now show that a streamlined genetic testing model could substantially shorten the time to diagnosis.

University of Queensland (Brisbane, Australia) researchers, working with Children’s Health Queensland, evaluated a new model of care for genomic testing in pediatric inborn errors of immunity. The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. Under the model, diagnosis waiting times could fall from 12 months to as little as two weeks.

The study examined nine years of genetic test data from 322 children tested through Queensland’s pediatric immunology service. Researchers assessed how the new testing process could improve testing rates and reduce unnecessary procedures. The analysis found that 30% of cases involved duplicate blood tests that were not needed.

The findings also showed that once a genetic diagnosis was made, the treatment plan changed in 90% of cases. Treatments for these conditions can include stem cell transplants, blood antibody infusions or infection prevention, depending on the condition. The study, “Evaluating Genomic Testing in Pediatric Inborn Errors of Immunity: An Optimal Model of Care,” was published in the Journal of Clinical Immunology.

The model also incorporates multidisciplinary team meetings in which specialists share knowledge on patient cases. According to Queensland Children’s Hospital, this structure reduces the need for families to move between multiple specialists. The study was conducted by the University of Queensland and Children’s Health Queensland.

“A faster result and diagnosis mean we can start targeted treatments early, which leads to fewer cumulative problems and less organ damage and increases the chance of kids leading a more normal life and attending school rather than being in and out of the hospital,” said Dr. Peter McNaughton, immunologist at Queensland Children’s Hospital.

“We regularly hold multidisciplinary team meetings where all specialists involved share knowledge on patient cases, which in turn allows everyone to improve their skills and cuts out the need for patients to be referred to several different specialists. This new model of care really is a team effort, and it’s making a huge difference to patients’ lives,” said Dr. McNaughton.

Related Links
University of Queensland
Queensland Children’s Hospital


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.